PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
Clinical trial NCT01916135 · COMPLETED
Trial details
- NCT number
- NCT01916135
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2020-04-23
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.